Zoetis (ZTS) Net Income towards Common Stockholders Growth (3y) (2015 - 2026)
Powered by 
Analysis
Zoetis (ZTS) Net Income towards Common Stockholders Growth (3y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.64 Bn | 40.44 Bn | 779.09 Mn | 14.70% |
| 2 | Zoetis | 30.58 Bn | 28.90 Bn | 1.05 Bn | -0.23% |
| 3 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn | 36.74% |
| 4 | Phibro Animal Health | 1.49 Bn | 1.41 Bn | 134.40 Mn | 36.15% |
| 5 | Immucell | 89.92 Mn | 81.06 Mn | 2.44 Mn | 49.33% |
| 6 | Zhengye Biotechnology Holding | 74.81 Mn | 67.72 Mn | - | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | -350.08% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.23% |
| Mar 31, 2026 | 2.84% |
| Dec 31, 2025 | 8.73% |
| Sep 30, 2025 | 9.97% |
| Jun 30, 2025 | 10.83% |
| Mar 31, 2025 | 2.07% |
| Dec 31, 2024 | 13.10% |
| Sep 30, 2024 | 9.87% |
| Jun 30, 2024 | 7.04% |
| Mar 31, 2024 | 2.83% |
| Dec 31, 2023 | 15.67% |
| Sep 30, 2023 | 6.30% |
| Jun 30, 2023 | 21.85% |
| Mar 31, 2023 | 11.93% |
| Dec 31, 2022 | 10.65% |
| Sep 30, 2022 | 15.49% |
| Jun 30, 2022 | 21.78% |
| Mar 31, 2022 | 32.57% |
| Dec 31, 2021 | 6.58% |
| Sep 30, 2021 | 23.84% |